Background—The mechanisms behind the beneficial effects of renin-angiotensin system
blockade after myocardial infarction (MI) are not fully elucidated but may include interference …

The existence of a local renin—angiotensin system in the heart is still a controversial issue.
This review discusses the evidence, obtained from studies in cardiac cells, in isolated …

Angiotensin (Ang) II type 1 (AT 1 ) receptors account for the majority of the cardiovascular
effects Ang II, including vasoconstriction and growth stimulation. Recent evidence, mainly …

Several studies suggest that a calcitonin gene‐related peptide (CGRP) receptor antagonist
may have antimigraine properties, most probably via the inhibition of CGRP‐induced cranial …

Objective: To study whether cardiac interstitial fluid levels of angiotensin I and II (Aug I and II)
can be monitored in vivo, using the microdialysis technique, and to assess the contribution …

1 Angiotensin (Ang) II type 2 (AT 2 ) receptors are believed to counteract Ang II type 1 (AT 1
) receptor‐mediated effects. Here, we investigated AT 2 receptor‐mediated effects on …

We investigated why angiotensin (Ang) I and II induce vasoconstriction with similar potencies,
although Ang I‐II conversion is limited. Construction of concentration‐response curves to …

Intake of drugs may influence the interpretation of laboratory test results. Knowledge and
correct interpretation of possible drug-laboratory test interactions (DLTIs) is important for …

To investigate the functional consequences of postinfarct cardiac angiotensin (ANG) type 2 (AT
2 ) receptor upregulation, rats underwent coronary artery ligation or sham operation and …

The beneficial effects of renin-angiotensin system blockers on cardiac structure and function
are usually explained based on the capacity of these drugs to interfere with angiotensin II at …